Article

Antiviral activity of influenza A virus defective interfering particles against SARS-CoV-2 replication <i>in vitro</i> through stimulation of innate immunity

2021-02-19

Abstract excerpt

SARS-CoV-2 causing COVID-19 emerged in late 2019 and resulted in a devastating pandemic. Although the first approved vaccines were already administered by the end of 2020, worldwide vaccine availability is still limited. Moreover, immune escape variants of the virus are emerging against which the current vaccines may confer only limited protection. Further, existing antivirals and treatment options against COVID-1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c7ef8543-9a10-570b-9f13-b195f970fbb0
DOI: 10.1101/2021.02.19.431972

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antiviral activity of influenza A virus defective interfering particles against SARS-CoV-2 replication <i>in vitro</i> through stimulation of innate immunityDOI 10.1101/2021.02.19.431972Read

SARS-CoV-2 replication triggers an MDA-5-dependent interferon production which is unable to efficiently control replicationSemantic proximity Read

Multiple layers of innate immune response antagonism of SARS-CoV-2Semantic proximity Read

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A virusesSemantic proximity Read

Type I interferons and SARS-CoV-2: from cells to organismsSemantic proximity Read

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A virusesSemantic proximity Read

Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial CulturesSemantic proximity Read

Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial CulturesSemantic proximity Read

SARS-CoV-2 Triggers an MDA-5-Dependent Interferon Response Which Is Unable To Control Replication in Lung Epithelial CellsSemantic proximity Read

Prospects for RNAi Therapy of COVID-19Semantic proximity Read

Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epitheliumSemantic proximity Read

Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responsesSemantic proximity Read

An Endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cellsSemantic proximity Read